Fischer Medical Ventures Issues Corrigendum to FY26 Annual Report

Fischer Medical Ventures Ltd has issued a corrigendum to its Annual Report for the financial year 2025-26, which was previously despatched to shareholders on September 7th, 2026. The company is rectifying several inadvertent errors and omissions across various sections of the report. These corrections include updates to financial highlights, auditor's reports (UDIN), paid-up equity share capital, and tables related to financial risk management, foreign currency exposure, and maturity analysis of assets and liabilities. The revised Annual Report, incorporating these changes, is attached for stakeholders' reference. The company is focused on its 'Next Phase of Innovation-Led Growth', aiming to scale its imaging portfolio and healthcare technologies.